Please login to the form below

Not currently logged in
Email:
Password:

Shire set to make move for Cubist

Shire Pharmaceuticals is planning a takeover of US-based Cubist Pharmaceuticals in a multi-billion pound deal, according to a UK media report

Shire Pharmaceuticals is planning takeover of US-based Cubist Pharmaceuticals in a multi-billion pound deal, according to a UK media report.

An article in The Daily Telegraph claims industry rumours are suggesting that Shire approached Cubist about a month ago with a $44.5-a-share deal, and that the two companies have been in discussions since.

Shire, which acquired Advanced BioHealing last week in a £460m deal, is reported to be keen to expand as a way fending off potential bidders itself.

Cubist sells an antibiotic called Cubicin, which is used to treat complex skin infections and the superbug MRSA.

Speaking to PMLiVE, Shire said it declines to comment on industry speculation.

Cubist was available to comment at the time of writing.

24th May 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Article
How will COVID-19 affect uptake of vaccinations against other diseases?...
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma....
Podcast
Living With Chronic Illness (Series one)...

Infographics